REFERENCES
- Abate C., Patel L., Rauscher F. J., 3rd, Curran T. Redox regulation of fos and jun DNA-binding activity in vitro. Science 1990; 249: 1157–1161
- Andrejko K. M., Chen J., Deutschman C. S. Intrahepatic STAT-3 activation and acute phase gene expression predict outcome after CLP sepsis in the rat. Am. J. Physiol. 1998; 27: G1423–1429
- Carpagnano G. E., Resta O., Foschino-Barbaro M. P., Spanevello A., Stefano A., Di Gioia G., Serviddio G., Gramiccioni E. Exhaled Interleukine-6 and 8-isoprostane in chronic obstructive pulmonary disease: Effect of carbocysteine lysine salt monohydrate (SCMC-Lys). Eur. J. Pharmacol. 2004; 505: 169–175
- Dinkova-Kostova A. T., Holtzclaw W. D., Kensler T. W. The role of Keap1 in cellular protective responses. Chem. Res. Toxicol 2005; 18: 1779–1791
- Hardardottir I., Grunfeld C., Feingold K. R. Effects of endotoxin on lipid metabolism. Biochem. Soc. Trans. 1995; 23: 1013–1018
- Hyson C., Sadler M. Cross sensitivity of skin rashes with antiepileptic drugs. Can. J. Neurol. Sci. 1997; 24: 245–249
- Kwak M. K., Wakabayashi N., Itoh K., Motohashi H., Yamamoto M., Kensler T. W. Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival. J. Biol. Chem. 2003; 278: 8135–8145
- Leeder J. S. Mechanisms of idiosyncratic hypersensitivity reactions to antiepileptic drugs. Epilepsia 1998; 39(S7)S8–16
- Leone A. M., Kao L. M., McMillian M. K., Nie A. Y., Parker J. B., Kelley M. F., Usuki E., Parkinson A., Lord P. G., Johnson M. D. Evaluation of felbamate and other antiepileptic drug toxicity potential based on hepatic protein covalent binding and gene expression. Chem. Res. Toxicol. 2007; 20: 600–608
- Leung P. S., Gershwin M. E. The immunobiology of heat shock proteins. J. Invest. Allergol. Clin. Immunol. 1991; 1: 23–30
- Lu W., Uetrecht J. Peroxidase-mediated bioactivation of hydroxylated metabolites of carbamazepine and phenytoin. Drug Metab. Dispos. 2008, (in press)
- McMillian M., Nie A. Y., Parker J. B., Leone A., Bryant S., Kemmerer M., Herlich J., Liu Y., Yieh L., Bittner A., Liu X., Wan J., Johnson M. D. A gene expression signature for oxidant stress/reactive metabolites in rat liver. Biochem. Pharmacol. 2004a; 68: 2249–2261
- McMillian M., Nie A. Y., Parker J. B., Leone A., Kemmerer M., Bryant S., Herlich J. J., Yieh L., Bittner A., Liu X., Wan J., Johnson M. D. Inverse gene expression patterns for macrophage activating hepatotoxicants and peroxisome proliferators in rat liver. Biochem. Pharmacol. 2004b; 67: 2141–2165
- McMillian M., Nie A., Parker J. B., Leone A., Kemmerer M., Bryant S., Herlich J., Yieh L., Bittner A., Liu X., Wan J., Johnson M. D., Lord P. Drug-induced oxidative stress in rat liver from a toxicogenomics perspective. Toxicol. Appl. Pharmacol. 2005; 207(S2)171–178
- Pahl H. L., Baeuerle P. A. Oxygen and the control of gene expression. Bioessays 1994; 16: 497–502
- Seguin B., Uetrecht J. The danger hypothesis applied to idiosyncratic drug reactions. Curr. Opin. Allergy Clin. Immunol. 2003; 3: 235–242
- Shear N. H., Spielberg S. P. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J. Clin. Invest. 1988; 82: 1826–1832
- Shen G., Jeong W. S., Hu R., Kong A. N. Regulation of Nrf2, NF-κ B, and AP-1 signaling pathways by chemopreventive agents. Antioxid. Redox Signal 2005; 7: 1648–1663
- Talalay P., Dinkova-Kostova A. T., Holtzclaw W. D. Importance of Phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis. Adv. Enzyme Regul. 2003; 43: 121–134
- Thomas R. S., Rank D. R., Penn S. G., Zastrow G. M., Hayes K. R., Pande K., Glover E., Silander T., Craven M. W., Reddy J. K., Jovanovich S. B., Bradfield C. A. Identification of toxicologically predictive gene sets using cDNA microarrays. Mol. Pharmacol. 2001; 60: 1189–1194